Abstract Purpose of Review Metabolic-associated fatty liver disease (MAFLD) is a condition
of fat accumulation in the liver that occurs in the majority of patients in combination with …

Nonalcoholic fatty liver disease (NAFLD), sarcopenia and sarcopenic obesity (SO) are
highly prevalent conditions that may coexist, especially in the aging population, without any …

Plastic pollution in the world is widespread and growing. The environment is swamped with
nanoplastics (< 100 nm), and the health consequences of these less visible pollutants are …

Background The diagnosis and comprehension of nonalcoholic fatty liver disease (NAFLD),
recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD) are …

The prevalence of metabolic-associated fatty liver disease (MAFLD) has increased
substantially in recent years because of the global obesity pandemic. MAFLD, now …

Nonalcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver
diseases in the world. The risk factor for NAFLD is often considered to be obesity, but it can …

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than 30% of
the world's adult population. While it is associated with obesity and metabolic syndrome …

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of conditions,
progressing from mild steatosis to advanced fibrosis. Sarcopenia, characterized by …

Objectives To determine the association of non-alcoholic fatty liver disease (NAFLD) with the
incidence of sarcopenia. Design Systematic review and meta-analysis of observational …

Nonalcoholic fatty liver disease (NAFLD) is currently the main cause of chronic liver disease
worldwide, and it can progress to hepatitis, liver fibrosis, liver cirrhosis, and even …